Skip to main content

Table 1 Patient characteristics

From: Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging

Variable

Value

PCa

BPH

Patients (n, %)

90 (44.5)

112 (55.5)

Age (years) a

68.9±7.4

63.5±8.9

PSA level (ng/ml) b

14.88(9.05, 30.13)

9.81(7.26, 15.01)

Lesion volume (ml) b

2.50(1.10, 6.00)

1.05(0.70, 1.70)

PI-RADS score b

5 (4, 5)

2 (2, 2)

Gleason score

 3+3 (n, %)

27 (13.4)

/

 3+4 (n, %)

17 (8.4)

/

 4+3 (n, %)

14 (6.9)

/

 ≥8 (n, %)

32 (15.8)

/

  1. PCa prostate cancer, BPH benign prostatic hypertrophy, PSA prostate-specific antigen, PI-RADS prostate imaging reporting and data system
  2. a, and b, data are expressed as the mean ± standard deviation and the median (1st and 3rd quartile ranges), respectively